The management of chronic diseases remains a significant infrastructural challenge across underserved communities in Africa. Pana+Care, a tech-enabled chronic care network founded by Beverly Senda, is strategically addressing this void by creating a scalable model that enhances service delivery for hypertension and diabetes patients across Kenya. Rather than relying on centralized infrastructure, Pana+Care empowers local clinics, transforming them into reliable hubs for specialist-led consultation and sustained patient management.
Pana+Care’s core innovation lies in its deployment of real-time, three-way teleconsultation services. This technology transcends geographic barriers by connecting specialists directly with local healthcare providers and the patient simultaneously. This system ensures crucial continuity of care, a key determinant of positive chronic disease outcomes, while drastically reducing the financial and logistical strain on patients who would otherwise need to travel long distances for specialized attention. This model not only elevates the quality of care but also strengthens the operational capacity of frontline community clinics.
The market validation for Pana+Care’s impactful model is compelling. The company’s financial stability was recently affirmed by a $10,000 SAFE investment from the African Impact Challenge at a $1.5M valuation cap. This investment traction, combined with the company’s selection for the HealthTech Hub Africa (HTHA) 2025 cohort, positions Pana+Care as a pivotal player in the HealthTech ecosystem. Furthermore, being named one of the Top 7 Women-led Startups in Kenya by Standard Chartered Bank and earning a two-time African Union Youth Start-Up Award underscores the company’s dual success in technological innovation and strategic leadership. Pana+Care is proving that strategic technology deployment can yield “Real People. Real Care. Real Impact.”
